{"id":13874,"date":"2022-05-12T13:48:45","date_gmt":"2022-05-12T17:48:45","guid":{"rendered":"https:\/\/imedcprod.wpengine.com\/?page_id=13874"},"modified":"2025-01-29T09:14:44","modified_gmt":"2025-01-29T14:14:44","slug":"directives-sur-la-concurrence","status":"publish","type":"page","link":"https:\/\/innovativemedicines.ca\/fr\/directives-sur-la-concurrence\/","title":{"rendered":"Directives sur la concurrence"},"content":{"rendered":"\n
<\/span>\"\"
\n\n
\n

Directives sur la concurrence<\/h1>\n<\/div><\/div>\n\n<\/div><\/div>\n\n\n\n
\n

Orientations de M\u00e9dicaments novateurs Canada relatives au droit de la concurrence<\/h2>\n\n\n\n

M\u00e9dicaments novateurs Canada et ses membres sont engag\u00e9s \u00e0 mener les activit\u00e9s de l\u2019association en conformit\u00e9 avec le droit canadien de la concurrence. Cela est essentiel pour la cr\u00e9dibilit\u00e9 et la validit\u00e9 de M\u00e9dicaments novateurs Canada comme organisation fonctionnelle. Alors que les associations professionnelles jouent un r\u00f4le l\u00e9gitime dans la d\u00e9fense de positions de politiques publiques, un comportement anticoncurrentiel peut se produire.
M\u00e9dicaments novateurs Canada et ses membres s\u2019engagent \u00e0 mener leurs activit\u00e9s l\u00e9galement, et reconnaissent que certaines activit\u00e9s peuvent avoir des implications en mati\u00e8re de droit de la concurrence, y compris toute entente expresse ou tacite entre concurrents concernant les prix, le refus collectif de faire des affaires, la r\u00e9partition des clients, la limitation de la production, ou l\u2019attribution de march\u00e9s g\u00e9ographiques. Les contraventions \u00e0 la Loi sur la concurrence peuvent avoir de graves cons\u00e9quences pour les organisations et leurs dirigeants, administrateurs et employ\u00e9s, notamment des peines d\u2019emprisonnement, des amendes importantes, et des recours collectifs en dommages. En plus de ces sanctions impos\u00e9es par la loi, les violations de la Loi sur la concurrence sont tr\u00e8s stigmatis\u00e9es et peuvent entra\u00eener d\u2019importantes perturbations op\u00e9rationnelles.<\/p>\n\n\n\n

M\u00e9dicaments novateurs Canada et ses membres s\u2019engagent \u00e0 d\u00e9velopper, mettre en \u0153uvre et maintenir des programmes de conformit\u00e9 cr\u00e9dibles et efficaces, con\u00e7us pour emp\u00eacher les membres d\u2019adopter ou de faciliter des discussions ou des activit\u00e9s qui pourraient \u00eatre consid\u00e9r\u00e9es comme anticoncurrentielles. Ce document est destin\u00e9 \u00e0 fournir des orientations g\u00e9n\u00e9rales pour assurer la conformit\u00e9 au droit de la concurrence. Toute question concernant ces orientations peut \u00eatre adress\u00e9e aux Affaires juridiques de M\u00e9dicaments novateurs Canada.<\/p>\n<\/div><\/div>\n\n\n\n

\n

Programmes de conformit\u00e9 en mati\u00e8re droit de la concurrence<\/h2>\n\n\n\n

M\u00e9dicaments novateurs Canada et ses membres doivent avoir et appliquer leurs propres programmes de conformit\u00e9 en mati\u00e8re de droit de la concurrence afin de pr\u00e9venir les infractions au droit canadien de la concurrence. Chaque programme de conformit\u00e9 doit indiquer la conduite \u00e0 tenir lors d\u2019interactions avec des concurrents, y compris :<\/p>\n\n\n\n

    \n
  1. Pr\u00e9ciser les sujets appropri\u00e9s et inappropri\u00e9s lorsqu\u2019ils traitent avec des concurrents, \u00e0 la fois dans des discussions officielles et informelles.<\/li>\n\n\n\n
  2. Exiger le respect du droit canadien de la concurrence et maintenir une perception de conformit\u00e9.<\/li>\n\n\n\n
  3. Obliger les employ\u00e9s, en fonction de leurs r\u00f4les respectifs, \u00e0 recevoir une formation continue en conformit\u00e9 pour observer les politiques internes en mati\u00e8re de droit de la concurrence, les Orientations de M\u00e9dicaments novateurs Canada relatives au droit de la concurrence et les Directives sur la concurrence r\u00e9gissant les r\u00e9unions de M\u00e9dicaments novateurs Canada.<\/li>\n\n\n\n
  4. Exiger la tenue de dossiers, pour une p\u00e9riode de temps raisonnable, attestant de la conformit\u00e9 et de la formation en mati\u00e8re de droit de la concurrence, comme les politiques internes en mati\u00e8re de droit de la concurrence, de m\u00eame que les ordres du jour et les proc\u00e8s-verbaux des r\u00e9unions.<\/li>\n<\/ol>\n\n\n\n

    Le respect des Orientations de M\u00e9dicaments novateurs Canada relatives au droit de la concurrence, telles que modifi\u00e9es de temps \u00e0 autre, est une condition d\u2019adh\u00e9sion \u00e0 M\u00e9dicaments novateurs Canada. Ces orientations sont entr\u00e9es en vigueur le 30 juin 2015 et ont \u00e9t\u00e9 mises \u00e0 jour en mars 2022 et en janvier\u00a02025.<\/p>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"

    Orientations de M\u00e9dicaments novateurs Canada relatives au droit de la concurrence M\u00e9dicaments novateurs Canada et ses membres sont engag\u00e9s \u00e0 […]<\/p>\n","protected":false},"author":12,"featured_media":13657,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"9178,9184,9192,9194,9196,9198","_relevanssi_noindex_reason":"","footnotes":""},"class_list":["post-13874","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nDirectives sur la concurrence - Innovative Medicines Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innovativemedicines.ca\/fr\/directives-sur-la-concurrence\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Directives sur la concurrence - Innovative Medicines Canada\" \/>\n<meta property=\"og:description\" content=\"Orientations de M\u00e9dicaments novateurs Canada relatives au droit de la concurrence M\u00e9dicaments novateurs Canada et ses membres sont engag\u00e9s \u00e0 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innovativemedicines.ca\/fr\/directives-sur-la-concurrence\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovative Medicines Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-29T14:14:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/competition-guidelines-hero.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1281\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/directives-sur-la-concurrence\\\/\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/directives-sur-la-concurrence\\\/\",\"name\":\"Directives sur la concurrence - Innovative Medicines Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/directives-sur-la-concurrence\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/directives-sur-la-concurrence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/competition-guidelines-hero.jpg\",\"datePublished\":\"2022-05-12T17:48:45+00:00\",\"dateModified\":\"2025-01-29T14:14:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/directives-sur-la-concurrence\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/directives-sur-la-concurrence\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/directives-sur-la-concurrence\\\/#primaryimage\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/competition-guidelines-hero.jpg\",\"contentUrl\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/competition-guidelines-hero.jpg\",\"width\":1920,\"height\":1281},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/directives-sur-la-concurrence\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Directives sur la concurrence\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/\",\"name\":\"Innovative Medicines Canada\",\"description\":\"Transforming Canadians\u2019 lives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Directives sur la concurrence - Innovative Medicines Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innovativemedicines.ca\/fr\/directives-sur-la-concurrence\/","og_locale":"fr_FR","og_type":"article","og_title":"Directives sur la concurrence - Innovative Medicines Canada","og_description":"Orientations de M\u00e9dicaments novateurs Canada relatives au droit de la concurrence M\u00e9dicaments novateurs Canada et ses membres sont engag\u00e9s \u00e0 […]","og_url":"https:\/\/innovativemedicines.ca\/fr\/directives-sur-la-concurrence\/","og_site_name":"Innovative Medicines Canada","article_modified_time":"2025-01-29T14:14:44+00:00","og_image":[{"width":1920,"height":1281,"url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/competition-guidelines-hero.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/innovativemedicines.ca\/fr\/directives-sur-la-concurrence\/","url":"https:\/\/innovativemedicines.ca\/fr\/directives-sur-la-concurrence\/","name":"Directives sur la concurrence - Innovative Medicines Canada","isPartOf":{"@id":"https:\/\/innovativemedicines.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/innovativemedicines.ca\/fr\/directives-sur-la-concurrence\/#primaryimage"},"image":{"@id":"https:\/\/innovativemedicines.ca\/fr\/directives-sur-la-concurrence\/#primaryimage"},"thumbnailUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/competition-guidelines-hero.jpg","datePublished":"2022-05-12T17:48:45+00:00","dateModified":"2025-01-29T14:14:44+00:00","breadcrumb":{"@id":"https:\/\/innovativemedicines.ca\/fr\/directives-sur-la-concurrence\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innovativemedicines.ca\/fr\/directives-sur-la-concurrence\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/innovativemedicines.ca\/fr\/directives-sur-la-concurrence\/#primaryimage","url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/competition-guidelines-hero.jpg","contentUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/competition-guidelines-hero.jpg","width":1920,"height":1281},{"@type":"BreadcrumbList","@id":"https:\/\/innovativemedicines.ca\/fr\/directives-sur-la-concurrence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innovativemedicines.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Directives sur la concurrence"}]},{"@type":"WebSite","@id":"https:\/\/innovativemedicines.ca\/fr\/#website","url":"https:\/\/innovativemedicines.ca\/fr\/","name":"Innovative Medicines Canada","description":"Transforming Canadians\u2019 lives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/pages\/13874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/comments?post=13874"}],"version-history":[{"count":1,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/pages\/13874\/revisions"}],"predecessor-version":[{"id":17589,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/pages\/13874\/revisions\/17589"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media\/13657"}],"wp:attachment":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media?parent=13874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}